Other suggestive findings for prostate cancer include SNPs in a variety of genes such as F13A1 expression of which has been associated with bone metastasis in prostate cancer [36], ANXA4 which is up-regulated in gastric and other cancers [17], NSD1 where cryptic translocations may be involved in AML occurrence [37] and MUC12, expression of which has been reported to be a prognostic marker in colon cancer [38]. This evidence concerns the gene ANXA4 and prostate carcinoma.